LFVN Lifevantage Corp

$6.47 +5.37%

Healthcare · Pharmaceutical Preparations

Lifevantage Corp (LFVN) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $82 million. Shares last traded at $6.47, 56.7% below their 52-week high. Over the past year the stock is down 49.3%. LFVN trades at a price-to-earnings ratio of 8.32, below the Pharmaceutical Preparations median of 16.82. Net profit margin is 4.3%, above the peer median of -0.1%. Revenue grew 14.2% year over year. The shares yield 2.7% in dividends.

Market Cap

$82M

Shares Out

12.6M

EPS (TTM)

$1.26

P/E Ratio

5.13

P/S Ratio

0.36

P/B Ratio

2.45

Dividend / Share

$0.18

Dividend Yield

2.70%

52-Week High

$14.94

52-Week Low

$3.90

Volume

11,065

Avg Vol (3m)

10,476.587

Performance

-32.07%

+22.54%

+36.21%

+2.05%

YTD

+6.94%

-49.25%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

44.52

SMA (50)

$6.26

SMA (200)

$6.73

Price vs SMA50

+3.33%

Price vs SMA200

-3.87%

ATR (14)

$1.36

Financials

Revenue

$229M

Net Income

$10M

Gross Margin

80.4%

Operating Margin

5.3%

Net Margin

4.3%

Return on Equity

29.4%

Return on Assets

15.8%

Current Ratio

1.96

Debt / Equity

0.00

Revenue Growth (YoY)

+14.2%

Latest reported annual period ending 2025-06-30 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q3 2026	$0.30	2026-05-06
Q2 2026	$0.19	2026-02-04
Q1 2026	$0.17	2025-11-04
FY 2025	$0.75	2025-09-04
Q3 2026	$0.60	2026-05-06
Q2 2026	$0.34	2026-02-04

Full earnings history →

Pharmaceutical Preparations peers

LFVN vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

8.32 / 16.82 med

-50% discount

P/S vs peers

0.36 / 3.54 med

-90% discount

Net margin vs peers

4.3% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.